Ora Biomedical, Inc.
About Ora Biomedical, Inc.
Ora Biomedical, Inc. is a privately held biotechnology company founded in 2022 and headquartered in Seattle, WA. It develops longevity interventions and drug discovery services using its WormBot-AI platform, which combines AI, robotics, and C. elegans to screen compounds for effects on lifespan and healthspan. The company was launched out of the Kaeberlein Lab at the University of Washington and has built one of the largest lifespan datasets from a single platform. It offers screening services to academic and industry partners in geroscience, skin health, and radiation care.
Key highlights
- Ora has screened around 10,000 compounds for lifespan effects using its WormBot-AI platform.
- The company completed a $50K subproject funding for the largest mTOR modulator screening to date.
- Co-founders include Brian Kennedy and Ben Blue, with ties to University of Washington and NUS.
- Ora is soliciting partnerships for screening services in aging and disease models.
Tech stack
Ask StreetZero about Ora Biomedical, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account